CD4+ T-cell-derived IFNγ could increase microglial MHCII expression, as observed in our analysis, and then promote microglial phagocytosis of GBM tumor, in a way resembling the report of anti-CTLA-4 treatment53. The gene discussed is IFNG; the disease is glioblastoma.